Literature DB >> 10548266

Cocaine produces panic-like flight responses in mice in the mouse defense test battery.

R J Blanchard1, J N Kaawaloa, M A Hebert, D C Blanchard.   

Abstract

There is an emerging body of clinical evidence that cocaine use in humans can result in serious fear or panic-related emotional disturbances. The present study evaluated the effects of cocaine administration upon defensive responses of mice to a predator (rat) in a Mouse Defense Test Battery (MDTB) that permits the display of the full range of the mouse defensive behaviors: avoidance/escape, flight, freezing, defensive upright, and defensive threat and attack. Mice were tested 30 min following intraperitoneal (IP) injections of either 0, 10, 20, or 30 mg/kg cocaine hydrochloride suspended in physiological saline. Cocaine produced an increase in flight and escape responses throughout the subtests comprising the MDTB. The percentage of subjects exhibiting escape increased in cocaine-treated mice in the Predator Avoidance Test. Cocaine increased mean flight speed and maximum flight speed in the Flight/Chase Test; frequency of flight responses in the Straight Alley Test; and the number of flight attempts in the Forced Contact test. The predominance of flight responding throughout the tests masked any possible cocaine effects on other defenses. The present findings indicate that cocaine may exert its panic-producing effects by acting upon particular neurobehavioral systems subserving defensive behavior.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548266     DOI: 10.1016/s0091-3057(99)00126-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

1.  Preferences for cocaine- or pup-associated chambers differentiates otherwise behaviorally identical postpartum maternal rats.

Authors:  Brandi J Mattson; Sharon E Williams; Jay S Rosenblatt; Joan I Morrell
Journal:  Psychopharmacology (Berl)       Date:  2003-02-27       Impact factor: 4.530

2.  Effects of lidocaine-induced inactivation of the bed nucleus of the stria terminalis, the central or the basolateral nucleus of the amygdala on the opponent-process actions of self-administered cocaine in rats.

Authors:  Jennifer M Wenzel; Stephanie A Waldroup; Zachary M Haber; Zu-In Su; Osnat Ben-Shahar; Aaron Ettenberg
Journal:  Psychopharmacology (Berl)       Date:  2011-04-13       Impact factor: 4.530

3.  A subpopulation of neurochemically-identified ventral tegmental area dopamine neurons is excited by intravenous cocaine.

Authors:  Carlos A Mejias-Aponte; Changquan Ye; Antonello Bonci; Eugene A Kiyatkin; Marisela Morales
Journal:  J Neurosci       Date:  2015-02-04       Impact factor: 6.167

4.  Regulation of the ventral tegmental area by the bed nucleus of the stria terminalis is required for expression of cocaine preference.

Authors:  Gregory C Sartor; Gary Aston-Jones
Journal:  Eur J Neurosci       Date:  2012-10-08       Impact factor: 3.386

5.  Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih.

Authors:  M J Wanat; F W Hopf; G D Stuber; P E M Phillips; A Bonci
Journal:  J Physiol       Date:  2008-02-28       Impact factor: 5.182

6.  Overexpression of DeltaFosB is associated with attenuated cocaine-induced suppression of saccharin intake in mice.

Authors:  Christopher S Freet; Cathy Steffen; Eric J Nestler; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2009-04       Impact factor: 1.912

7.  Ethological Evaluation of the Effects of Social Defeat Stress in Mice: Beyond the Social Interaction Ratio.

Authors:  Aron M Henriques-Alves; Claudio M Queiroz
Journal:  Front Behav Neurosci       Date:  2016-02-03       Impact factor: 3.558

8.  High anxiety is a predisposing endophenotype for loss of control over cocaine, but not heroin, self-administration in rats.

Authors:  Ruth Dilleen; Yann Pelloux; Adam C Mar; Anna Molander; Trevor W Robbins; Barry J Everitt; Jeffrey W Dalley; David Belin
Journal:  Psychopharmacology (Berl)       Date:  2012-01-14       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.